Last Updated: August 25, 2026

IFOSFAMIDE/MESNA KIT Drug Patent Profile

Name: IFOSFAMIDE/MESNA KIT Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Ifosfamide/mesna Kit patents expire, and when can generic versions of Ifosfamide/mesna Kit launch?

Ifosfamide/mesna Kit is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in IFOSFAMIDE/MESNA KIT is ifosfamide; mesna. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for IFOSFAMIDE/MESNA KIT?
What are the global sales for IFOSFAMIDE/MESNA KIT?
What is Average Wholesale Price for IFOSFAMIDE/MESNA KIT?

Summary for IFOSFAMIDE/MESNA KIT

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	482
DailyMed Link:	IFOSFAMIDE/MESNA KIT at DailyMed

Drug patent expirations by year for IFOSFAMIDE/MESNA KIT

Recent Clinical Trials for IFOSFAMIDE/MESNA KIT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
USWM, LLC (dba US WorldMeds)	PHASE2
Milton S. Hershey Medical Center	PHASE2
Second Affiliated Hospital, School of Medicine, Zhejiang University	PHASE2

See all IFOSFAMIDE/MESNA KIT clinical trials

US Patents and Regulatory Information for IFOSFAMIDE/MESNA KIT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	IFOSFAMIDE/MESNA KIT	ifosfamide; mesna	INJECTABLE;INTRAVENOUS	075874-001	Feb 26, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	IFOSFAMIDE/MESNA KIT	ifosfamide; mesna	INJECTABLE;INTRAVENOUS	075874-002	Feb 26, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.